Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 15 | 2023 | 179 | 5.950 |
Why?
|
| Thrombosis | 7 | 2023 | 195 | 2.880 |
Why?
|
| Platelet Activation | 6 | 2023 | 89 | 1.910 |
Why?
|
| Influenza, Human | 2 | 2021 | 193 | 1.180 |
Why?
|
| Hemostasis | 4 | 2020 | 27 | 1.080 |
Why?
|
| Megakaryocytes | 4 | 2022 | 20 | 0.960 |
Why?
|
| Receptor, Adenosine A2B | 7 | 2014 | 10 | 0.930 |
Why?
|
| Adaptive Immunity | 2 | 2022 | 90 | 0.880 |
Why?
|
| Cardiovascular System | 1 | 2023 | 41 | 0.820 |
Why?
|
| Atherosclerosis | 5 | 2014 | 147 | 0.780 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 82 | 0.730 |
Why?
|
| Plague | 1 | 2020 | 23 | 0.710 |
Why?
|
| Yersinia pestis | 1 | 2020 | 33 | 0.710 |
Why?
|
| Virion | 1 | 2020 | 117 | 0.670 |
Why?
|
| Betacoronavirus | 2 | 2020 | 159 | 0.670 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 186 | 0.620 |
Why?
|
| Immunity, Innate | 2 | 2022 | 766 | 0.610 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 198 | 0.610 |
Why?
|
| DNA Viruses | 1 | 2018 | 15 | 0.610 |
Why?
|
| Herpesviridae | 1 | 2018 | 14 | 0.600 |
Why?
|
| Influenza A virus | 1 | 2019 | 117 | 0.590 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2019 | 97 | 0.590 |
Why?
|
| Toll-Like Receptors | 2 | 2020 | 434 | 0.570 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 176 | 0.560 |
Why?
|
| RNA, Viral | 1 | 2018 | 265 | 0.550 |
Why?
|
| Pandemics | 2 | 2020 | 606 | 0.540 |
Why?
|
| Apoptosis | 1 | 2021 | 1038 | 0.520 |
Why?
|
| MicroRNAs | 2 | 2020 | 617 | 0.500 |
Why?
|
| Adenosine | 2 | 2012 | 70 | 0.490 |
Why?
|
| Membrane Glycoproteins | 2 | 2019 | 669 | 0.490 |
Why?
|
| Coxsackievirus Infections | 1 | 2015 | 12 | 0.490 |
Why?
|
| Enterovirus B, Human | 1 | 2015 | 22 | 0.480 |
Why?
|
| Animals | 20 | 2023 | 19618 | 0.460 |
Why?
|
| Cardiovirus Infections | 1 | 2014 | 13 | 0.460 |
Why?
|
| Encephalomyocarditis virus | 1 | 2014 | 14 | 0.460 |
Why?
|
| Myocarditis | 1 | 2015 | 61 | 0.450 |
Why?
|
| Inflammation | 10 | 2022 | 1101 | 0.420 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2012 | 11 | 0.420 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 38 | 0.390 |
Why?
|
| Humans | 22 | 2023 | 59350 | 0.380 |
Why?
|
| Mice, Knockout | 10 | 2019 | 1988 | 0.360 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 827 | 0.280 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 2065 | 0.250 |
Why?
|
| Mice | 12 | 2023 | 10260 | 0.250 |
Why?
|
| Neutrophils | 2 | 2019 | 356 | 0.230 |
Why?
|
| Blotting, Western | 3 | 2021 | 595 | 0.220 |
Why?
|
| Male | 9 | 2021 | 27526 | 0.200 |
Why?
|
| A549 Cells | 1 | 2021 | 36 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 138 | 0.180 |
Why?
|
| Female | 9 | 2021 | 30845 | 0.180 |
Why?
|
| Risk Factors | 3 | 2017 | 4999 | 0.180 |
Why?
|
| Hibernation | 1 | 2020 | 10 | 0.180 |
Why?
|
| Ursidae | 1 | 2020 | 12 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2014 | 580 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 62 | 0.170 |
Why?
|
| Endocytosis | 1 | 2020 | 148 | 0.160 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 239 | 0.160 |
Why?
|
| Blood Vessels | 2 | 2012 | 61 | 0.160 |
Why?
|
| Complement C3 | 1 | 2019 | 61 | 0.160 |
Why?
|
| Extracellular Traps | 1 | 2019 | 40 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 140 | 0.160 |
Why?
|
| Collagen | 2 | 2016 | 121 | 0.150 |
Why?
|
| Mean Platelet Volume | 1 | 2017 | 4 | 0.140 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 697 | 0.140 |
Why?
|
| Dietary Fats | 3 | 2014 | 204 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 3193 | 0.130 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2016 | 3 | 0.130 |
Why?
|
| Forecasting | 1 | 2017 | 221 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 525 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 105 | 0.130 |
Why?
|
| Thrombophilia | 1 | 2016 | 15 | 0.130 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 164 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 249 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2017 | 177 | 0.130 |
Why?
|
| Obesity | 2 | 2014 | 1189 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2012 | 22 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 749 | 0.120 |
Why?
|
| Platelet Aggregation | 2 | 2016 | 59 | 0.120 |
Why?
|
| Adult | 3 | 2021 | 15746 | 0.120 |
Why?
|
| Cell Degranulation | 1 | 2014 | 20 | 0.120 |
Why?
|
| Hypertension | 1 | 2020 | 601 | 0.120 |
Why?
|
| Secretory Vesicles | 1 | 2014 | 23 | 0.120 |
Why?
|
| Platelet Count | 1 | 2014 | 33 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2015 | 119 | 0.110 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 209 | 0.110 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2014 | 9 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 169 | 0.110 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2014 | 143 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 250 | 0.110 |
Why?
|
| Foam Cells | 1 | 2012 | 4 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2017 | 485 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2012 | 2890 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 265 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 1235 | 0.100 |
Why?
|
| Sex Factors | 1 | 2015 | 959 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1470 | 0.100 |
Why?
|
| Middle Aged | 3 | 2019 | 16254 | 0.100 |
Why?
|
| Aged | 2 | 2019 | 13308 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2012 | 69 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 99 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2008 | 47 | 0.090 |
Why?
|
| Macrophages | 2 | 2014 | 1006 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1226 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 59 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2014 | 404 | 0.090 |
Why?
|
| Prognosis | 1 | 2015 | 1565 | 0.090 |
Why?
|
| Adenosine Diphosphate | 1 | 2010 | 59 | 0.080 |
Why?
|
| Homeostasis | 1 | 2012 | 340 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 847 | 0.080 |
Why?
|
| Biomarkers | 1 | 2015 | 1206 | 0.080 |
Why?
|
| Glucose | 1 | 2012 | 444 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5071 | 0.080 |
Why?
|
| Massachusetts | 1 | 2015 | 2086 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2020 | 363 | 0.080 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2008 | 13 | 0.080 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 64 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2008 | 32 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 1537 | 0.070 |
Why?
|
| Liver | 1 | 2011 | 785 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 855 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 211 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 675 | 0.060 |
Why?
|
| Platelet Adhesiveness | 2 | 2016 | 13 | 0.060 |
Why?
|
| Nanomedicine | 1 | 2022 | 24 | 0.050 |
Why?
|
| Adenosine A2 Receptor Agonists | 2 | 2012 | 6 | 0.050 |
Why?
|
| Immunity | 1 | 2022 | 96 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1221 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 142 | 0.050 |
Why?
|
| Antithrombin III | 1 | 2020 | 14 | 0.040 |
Why?
|
| Angiotensins | 1 | 2020 | 5 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 129 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 659 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 141 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 190 | 0.040 |
Why?
|
| Rats | 2 | 2016 | 1907 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2020 | 377 | 0.040 |
Why?
|
| Inpatients | 1 | 2020 | 296 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 2 | 2008 | 133 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1370 | 0.030 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 231 | 0.030 |
Why?
|
| Integrin alpha2beta1 | 1 | 2016 | 1 | 0.030 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2016 | 7 | 0.030 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 12 | 0.030 |
Why?
|
| Platelet Factor 4 | 1 | 2016 | 11 | 0.030 |
Why?
|
| Bacteroidaceae Infections | 1 | 2014 | 3 | 0.030 |
Why?
|
| Porphyromonas gingivalis | 1 | 2014 | 16 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2016 | 353 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 34 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 84 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 125 | 0.030 |
Why?
|
| Pyridines | 1 | 2014 | 98 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 500 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 185 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2012 | 23 | 0.030 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2012 | 5 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 201 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 255 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2012 | 58 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 461 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 861 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 255 | 0.020 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2010 | 4 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2014 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2010 | 143 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2010 | 91 | 0.020 |
Why?
|
| NADPH Oxidase 4 | 1 | 2008 | 5 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 687 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 644 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 201 | 0.020 |
Why?
|
| Aorta | 1 | 2008 | 103 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 569 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2006 | 3 | 0.020 |
Why?
|
| E-Selectin | 1 | 2006 | 19 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 645 | 0.020 |
Why?
|
| P-Selectin | 1 | 2006 | 26 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 52 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 1157 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2008 | 379 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 243 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2103 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 944 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 3567 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 906 | 0.010 |
Why?
|